Navigation Links
BIDMC scientists receive creativity awards from Prostate Cancer Foundation

BOSTON Two projects led by scientists at Beth Israel Deaconess Medical Center (BIDMC) have received funding from the Prostate Cancer Foundation (PCF) as part of their 2009 Creativity Awards program, which supports innovative ideas to improve the detection and treatment of prostate cancer.

The one-year awards were made to 10 projects at nine institutions throughout the U.S., with BIDMC the only institution in New England to be funded and the only institution to receive multiple awards.

PCF Creativity Awards were developed to aid the advancement of the world's most imaginative, new research ideas that are not currently funded by any existing government or private sources.

"We were impressed with the unique ideas represented by the applications we received. A rigorous peer review process vetted the 10 selected projects from a field of more than 300 applications representing 105 institutions in 11 countries," said Howard Soule, PhD, PCF executive vice president and chief scientist. "These awards feed our pipeline of compelling ideas to cultivate new solutions for the prostate cancer problem. Promising results will translate into better therapies for patients with advanced prostate cancer."

Towia Libermann, PhD, and Alan Rigby, PhD, will receive the Michael Vinecki Creativity Award for their work studying Ets factor binding sites on DNA, the first step in selecting candidate prostate cancer inhibitors. "We know that in 40 to 60 percent of prostate cancers, Ets factors are what lies behind both the initial disease and its progression," notes Libermann. He and Rigby will use a state-of-the-art computer-aided drug discovery platform developed in the Rigby laboratory to model the structure of these sites, with the ultimate goal of generating drug candidates to block prostate-cancer progression. Libermann is Director of the BIDMC Genomics and Proteomics Center and of the Dana-Farber/Harvard Cancer Center Proteomics Core in BIDMC's Division of Interdisciplinary Medicine and Biotechnology; Rigby is Interim Director of the Program in Drug Discovery and Target Validation in BIDMC's Center for Vascular Biology Research, Division of Molecular and Vascular Biology.

Pier Paolo Pandolfi, MD, PhD, Director of Research for BIDMC's Cancer Center will receive PCF's Dan Fogleberg Creativity Award for his work on cellular senescence. "Cellular senescence is a process whereby cancer cells 'go to sleep irreversibly,'" explains Pandolfi. Building on earlier work which identified a previously unknown form of senescence in prostate cancer cells, Pandolfi will use specialized animal models of prostate cancer to evaluate chemical compounds to achieve senescence in the cancer stem cell population, which is known to be extremely difficult to eradicate.


Contact: Bonnie Prescott
Beth Israel Deaconess Medical Center

Related medicine news :

1. Biotech company cofounded by BIDMC scientists targets natural killer T-cells
2. Healthcare Data Services (HDS) Announces Contract with Beth Israel Deaconess Physician Organization (BIDPO) and Beth Israel Deaconess Medical Center (BIDMC)
3. BIDMC Dyslexia Research Lab celebrates 25th anniversary
4. Scientists discover way to jumpstart bones healing process
5. Scripps research scientists model 3D structures of proteins that control human clock
6. Scientists Identify Key Gene That Protects Against Leukemia
7. Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium
8. Scientists Now Warn That White Wine Can Lead To Teeth Staining
9. Scientists Uncover New Weapon Against Huntingtons
10. Scientists show how a neuron gets its shape
11. Neuroscientists demonstrate link between brainwave acticity and visual perception
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve their ... The patient is doing more than filling out a survey; in many cases health ... increasing emphasis in health care and research on the importance of active engagement with ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: BPMX) ... developed an innovative way to use nonlinear optical imaging ... of new drugs. ... Conference will show how researchers from BioPharmX and the ... School used a suite of imaging techniques in what ...
(Date:10/10/2017)... 2017   West Pharmaceutical Services, Inc. (NYSE: ... drug administration, today shared the results of a study ... the intradermal administration of polio vaccines. The study results ... May 2017 by Dr. Ondrej Mach , Clinical ... Organization (WHO), and recently published in the journal ...
(Date:10/4/2017)... , Oct. 4, 2017 ... single-use, self-contained, illuminating medical devices, today announced regulatory ... Health Surveillance Agency (or Agência Nacional de Vigilância ... first single-use, cordless surgical retractor with integrated LED ... optimal access, illumination and exposure of a tissue ...
Breaking Medicine Technology: